Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline and amorphous forms of a compound for the targeted degradation of estrogen receptor

Crystalline and amorphous forms of a compound for the targeted degradation of estrogen receptor

US Patent 12162859 · Granted Dec 10, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of manufacturing a bifunctional compound2025
Polymorphs of phenyl pyrrole aminoguandium salts2025
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estr2025
Method of manufacturing a pharmaceutical composition2024
Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunct2024
Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunct2024
Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunct2024
Method of manufacturing a pharmaceutical composition2023
Sulcardine salts2022
Polymorphs and uses thereof2022
Sulcardine salts2021
Method of manufacturing a pharmaceutical composition2021